insights_auto
Why is RNAZ up 8.77%?
Dive Deeperchevron_right
RNAZ:NASDAQ
Transcode Therapeutics Inc
$1.86
arrow_upward
+8.77%(+0.15) 1D
$1.83
arrow_downward
-1.61% (-0.030)bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RNAZ...
Open
$1.78
High
$1.95
Low
$1.74
Mkt. cap
31.49M
Avg. vol.
73.82K
Volume
84.08K
52-wk high
$15.94
52-wk low
$1.52
EPS
-$50.76
Beta
1.25
Shares outstanding
16.93M
No. of employees
12
Open
$1.78
High
$1.95
Low
$1.74
Mkt. cap
31.49M
Avg. vol.
73.82K
Volume
84.08K
52-wk high
$15.94
52-wk low
$1.52
EPS
-$50.76
Beta
1.25
Shares outstanding
16.93M
No. of employees
12
News stories
From web sources and news partners
Simply Wall Street
·
7 minutes ago
Is ZoomInfo Technologies (GTM) Cheap As Its ClickUp Integration Sparks Fresh Interest?
MarketBeat
·
3 minutes ago
Eagle Financial Services Inc. (NASDAQ:EFSI) Stock Has Consensus Price Target of $43.75
AOL.com
·
39 minutes ago
Vanguard's S&P 500 Index Fund Charges About $3 a Year on $10,000. The Average Stock Fund Charges About $40.
Yahoo Finance
·
12 hours ago
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
About Transcode Therapeutics Inc
CEO-
Employees12
Founded2016
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitetranscodetherapeutics.com